RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Xtant Medical Holdings Stock

Xtant Medical Holdings ROCE 2024

Xtant Medical Holdings ROCE

-0.2

Ticker

XTNT

ISIN

US98420P3082

WKN

A2JDJS

In 2024, Xtant Medical Holdings's return on capital employed (ROCE) was -0.2, a 0.07% increase from the -0.2 ROCE in the previous year.

Xtant Medical Holdings Aktienanalyse

What does Xtant Medical Holdings do?

Xtant Medical Holdings Inc. is a leading provider of medical technology and biologics, specializing in the development, manufacturing, and marketing of innovative orthopedic solutions to support patients. The company was founded in 2013 and is headquartered in Belgrade, Montana, USA. The company is focused on two main divisions: Xtant Medical and Xspine Systems. Xtant Medical specializes in the development and sale of orthopedic implants and biologics for use in spinal, sports medicine, and extremity surgery. Xtant Medical's product range includes bone replacement substitutes such as allografts, synthetic bone graft products, autologs, and matrix. Xtant Medical's products are developed and distributed by an experienced and dedicated team of physicians, engineers, and scientists who are focused on delivering innovative products of the highest quality and safety. Xspine Systems specializes in the development of innovative surgical instruments and implants for spinal surgery. Xspine Systems' product range includes implants for the lumbar spine (LWS), cervical spine (HWS), and thoracic spine (TWS), as well as surgical instruments such as kits, drills, screws, and plates. Xspine Systems' products are characterized by excellent quality and innovation, enabling surgeons to provide precise and effective treatments for their patients. Xtant Medical has a strong focus on research and development. The company has an experienced team of scientists, engineers, and surgeons who are dedicated to developing innovative solutions for the most complex medical challenges. The company has extensive research and development programs that focus on the development of high-quality implants and biologic solutions for spinal, sports medicine, and extremity surgery. The company's products are based on scientific studies that are based on evidence-based principles to ensure they meet the needs of patients and surgeons. Xtant Medical is always striving to meet the needs of its customers by providing high-quality products and services. The company has adhered to the highest quality standards and procedures to ensure that its products meet the requirements of the industry. The company works closely with surgeons and clinicians to ensure that the products meet the requirements of surgeons and the needs of patients. Xtant Medical is a leading provider of medical technology and biologics, specializing in the development, manufacturing, and marketing of innovative orthopedic solutions to support patients. The company has earned an excellent reputation for its high-quality products and services and is constantly striving to exceed the expectations of its customers. Xtant Medical Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Xtant Medical Holdings's Return on Capital Employed (ROCE)

Xtant Medical Holdings's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Xtant Medical Holdings's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Xtant Medical Holdings's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Xtant Medical Holdings’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Xtant Medical Holdings stock

What is the ROCE (Return on Capital Employed) of Xtant Medical Holdings this year?

The ROCE of Xtant Medical Holdings is -0.2 undefined this year.

How has the ROCE (Return on Capital Employed) of Xtant Medical Holdings developed compared to the previous year?

The ROCE of Xtant Medical Holdings has increased by 0.07% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Xtant Medical Holdings?

A high Return on Capital Employed (ROCE) indicates that Xtant Medical Holdings has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Xtant Medical Holdings?

A low ROCE (Return on Capital Employed) can indicate that Xtant Medical Holdings has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Xtant Medical Holdings impact the company?

An increase in the ROCE of Xtant Medical Holdings can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Xtant Medical Holdings affect the company?

A decrease in ROCE of Xtant Medical Holdings can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Xtant Medical Holdings?

Some factors that can affect Xtant Medical Holdings's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Xtant Medical Holdings so important for investors?

The ROCE of Xtant Medical Holdings is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Xtant Medical Holdings take to improve the ROCE?

To improve the ROCE, Xtant Medical Holdings can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Xtant Medical Holdings pay?

Over the past 12 months, Xtant Medical Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xtant Medical Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of Xtant Medical Holdings?

The current dividend yield of Xtant Medical Holdings is .

When does Xtant Medical Holdings pay dividends?

Xtant Medical Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Xtant Medical Holdings?

Xtant Medical Holdings paid dividends every year for the past 0 years.

What is the dividend of Xtant Medical Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Xtant Medical Holdings located?

Xtant Medical Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Xtant Medical Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Xtant Medical Holdings from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.

When did Xtant Medical Holdings pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Xtant Medical Holdings in the year 2023?

In the year 2023, Xtant Medical Holdings distributed 0 USD as dividends.

In which currency does Xtant Medical Holdings pay out the dividend?

The dividends of Xtant Medical Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Xtant Medical Holdings

Our stock analysis for Xtant Medical Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xtant Medical Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.